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Abstract
Background: With the continued growth in the volume both of experimental G protein-coupled receptor (GPCR)
data and of the related peer-reviewed literature, the ability of GPCR researchers to keep up-to-date is becoming
increasingly curtailed.
Results: We present work that integrates the biological data and annotations in the GPCR information system
(GPCRDB) with next-generation methods for intelligently exploring, visualising and interacting with the scientific
articles used to disseminate them. This solution automatically retrieves relevant information from GPCRDB and
displays it both within and as an adjunct to an article.
Conclusions: This approach allows researchers to extract more knowledge more swiftly from literature. Importantly,
it allows reinterpretation of data in articles published before GPCR structure data became widely available, thereby
rescuing these valuable data from long-dormant sources.
Background
Recent decades have seen a massive increase in the amount
of data available to researchers. Revolutionary high-
throughput technologies have enabled data production on
an unprecedented scale in many areas of the life sciences.
To accommodate this increase in experimental data, we
have also witnessed a database explosion, with both the
number and size of specialised biological repositories grow-
ing enormously over the years [1]. Most of these resources
offer their own data formats, websites and programmatic
interfaces. This has made the task of retrieving information
increasingly difficult and complex [2].
GPCRDB [3] is one of the earliest examples of a
Molecular-class Specific Information System (MCSIS). It
collects, combines, validates and disseminates large
amounts of GPCR-related content, bringing together
information (such as sequences, structures, mutations
and oligomers) from other databases, and augmenting
this with manually annotated data (such as mutations
extracted from literature), as well as computationally-
derived multiple sequence alignments and homology
models. Its contents are validated, integrated, internally
consistent [4] and updated regularly [3]. GPCRDB thus
functions as a one-stop shop for GPCR-related knowl-
edge, relieving scientists of the burden of going through
the process of finding multiple data sources, of learning
how to use them, and of then retrieving, synthesising
and integrating the retrieved information.
Much of the routine practice of communicating scienti-
fic knowledge is conducted through the process of reading
and writing scientific papers, an invaluable method that
has been used successfully for hundreds of years. However,
it is now widely acknowledged that this approach imposes
considerable constraints upon the type and quantity of
biological information published: specifically, the data
used to generate hypotheses and to perform experiments
are not readily accessible to fellow researchers who use
the results of their peers’ publications.
Relating information between databases and literature
has become increasingly difficult with the growing quanti-
ties of data and documents available, and it is evident that
new solutions are required to address this problem [5,6].
When reading about a mutation, a scientist might, for
example, want to know the location of the mutated resi-
due in the structure, or find other articles describing the
same mutation. Although systems like GPCRDB provide
scientists with access to focused information derived from
the literature, subsequent exploration of concepts in
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related articles still poses practical hurdles (e.g., opening a
browser window, navigating to the database, searching for
the data).
With the goal of bridging the gap between data and
scientific articles, several initiatives have explored how to
enrich scientific literature with repository data, either by
manual annotation [7-9] or by automatic approaches
[10,11]. The results of these projects are encouraging, but
also point to what remains to be done. For example,
Shotton et al. [9] have explored the use of semantic
annotations, beautifully illustrating the possibilities of
these types of technologies. However, providing enhance-
ments of this quality on a routine basis is still far beyond
our reach; this impressive example is limited to one
paper, and a very large amount of manual input was
involved. One of the most promising automated initia-
tives, the Reflect [11] system, provides annotations for a
very large number of biological entities, covering genes,
proteins and a large number of small-molecule com-
pounds. These annotations contain an enormous wealth
of data and hyperlinks to a multitude of information sys-
tems. However, automation of the process carries the
price of a large number of errors; hence, vigilance and
caution are required, coupled with a significant amount
of manual effort to validate and disambiguate the results.
In addition, the aforementioned approaches all focus on
HTML/XML formats, and require users to read their
articles in a Web browser, ignoring the de facto standard
format of scientific literature: Adobe’s Portable Docu-
ment Format (PDF). This is by far the most popular
format for peer-reviewed science communication, for
reasons that include the benefits of their permanence,
device independence, and ubiquitous support and good
readability. It therefore makes sense to exploit the PDF;
the software tool Utopia Documents [12,13] was devel-
oped for just this purpose. Behaving like a familiar PDF
reader, Utopia Documents is a desktop application for
reading and exploring papers. Its strength lies in being
able to semantically annotate concepts in documents
with additional relevant information and links to online
resources.
We report here a technology that allows on-the-fly
annotation of GPCR-related PDF articles. By fully integrat-
ing the Utopia Documents PDF reader and the GPCRDB
information system, we can present to the scientist, in a
non-intrusive way, all possible data and information
related to the topics discussed in the article at hand. This
makes possible a paradigmatic change in the relationship
between the PDF-reading scientist and Internet-based data
resources, alleviating the troubles associated with navigat-
ing the many links between existing data and information
in this field. The scientist neither struggles to get access
to information related to topics within an article, nor is
swamped by unnecessary information that still needs
disambiguation; only data and information relevant to the
topic of the article is made available.
Implementation
The system comprises three parts: the Utopia Documents
reader; the GPCRDB; and a module that performs the
communication between the two. Users can annotate a
document with GPCR-specific information with a single
click, but, behind the scenes, the PDF annotation is a
multi-step process:
1. Extracting the text from the PDF document
2. Identifying concepts (species, proteins, residues
and mutations)
3. Creating relevant annotations based on GPCRDB
data
4. Adding the annotations to the document
1 and 4 are carried out by Utopia Documents, while 2
and 3 are performed by GPCRDB (Figure 1). The commu-
nication between the device running Utopia Documents
and GPCRDB is done from within Utopia Documents by a
GPCRDB-specific plugin. This plugin, written in the
Python programming language, makes use of the publicly
available Web service (SOAP) and Utopia’s plugin-API to
facilitate the communication and data exchanges between
the Utopia Documents reader at the scientist’s computer
and the remote GPCRDB computing facilities. Within the
plugin, the text is extracted from the PDF document and
sent via the Web service to GPCRDB. There, the text is
analysed automatically and annotations are created that
are passed back to the main Utopia client to be displayed
on the article as highlighted regions. More information on
plugins can be obtained from the paper by Attwood et al.
[13].
Identifying concepts
Concepts for which we can provide information (proteins,
residues and mutations) must be unambiguously identified
to be able to present users with relevant information.
Clearly, it is important to ensure that terms in the PDF are
correctly mapped to terms in GPCRDB. Concepts must be
found in the text and coupled to a unique database identi-
fier, a process referred to as normalization [14,15]. In the
case of a protein, this requires knowledge about the
species from which it originates. The term ‘rhodopsin’, for
example, cannot be normalised, whereas the words
‘human rhodopsin’ would map to the UniProtKB:Swiss-
Prot identifier ‘OPSD_HUMAN’. For residues and muta-
tions, each occurrence needs to be identified and asso-
ciated with one of the proteins mentioned in the text,
a process called grounding [16-18]: e.g., ‘Trp161’ is mean-
ingless, whereas ‘Trp161 in human rhodopsin’ maps to a
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unique residue in one specific protein, and is thus
grounded on a normalised protein.
It is beyond the scope of this article to provide an
exhaustive explanation of all algorithms and heuristics
involved in normalisation and grounding. However, at
the heart of both tasks lies the use of a metric based on
word distances, in which combinations of terms that are
close together in the text are favoured over more distant
combinations. The distance metrics are combined with a
number of heuristics, filters and validations. Some of the
heuristics have been described elsewhere [16,18,19],
while a series of related heuristics have been newly
designed and implemented. In the following sections, we
describe the most important steps involved in extracting
and identifying proteins, residues and mutations.
Protein identification and normalisation
Protein identification is the non-trivial task of pinpoint-
ing words that represent a gene or protein. We use a dic-
tionary-based approach. Dictionaries are populated with
gene identifiers, protein identifiers and protein descrip-
tions from all GPCRs in GPCRDB that are present in
UniProtKB:Swiss-Prot [20]. UniProtKB’s Swiss-Prot com-
ponent is used because of its consistent mapping between
protein sequences and their descriptions. Commonly
observed synonyms not present in the database-extracted
list were manually added to the dictionaries. The text is
scanned for gene or protein occurrences using approxi-
mate dictionary matching, allowing for some variability.
Separate dictionaries are created for gene identifiers, pro-
tein identifiers and protein descriptions, each with their
own scoring metric. This makes it possible to set high
penalties for mismatches between reference dictionary
entries and detected gene or protein identifiers, while
allowing more variability (i.e., the use of both Latin and
Greek characters in protein descriptions) when scoring
protein descriptions, taking into account their free-text
and relatively changeable nature. The Linnaeus [21] sys-
tem is used to find species occurrences in the text, and to
normalise these occurrences to NCBI taxonomy [22]
identifiers. The normalised species occurrences are then
used to complete the normalisation of the identified pro-
tein occurrences.
Mutation and residue identification and grounding
Identifying point mutations and residues involves two
subtasks. First, it is necessary to identify the mutation or
residue terms discussed in an article. Second, the identi-
fied residues and mutations must be grounded.
Three entities in the text need to be related to identify
point mutations: the wild type residue, the mutant residue,
and the position in the sequence where the substitution
occurred. Point mutations are represented in the literature
in a variety of ways. The most common representation is
in the form ‘XnY’, where × is the single-letter code for the
wild-type residue, n its location and Y the single-letter
code for the substituted residue (e.g., ‘D98F’ denotes a
change from aspartic acid to phenylalanine at position 98).
However, there are many variations on this theme, ranging
from the use of three-letter amino acid codes, as in
‘Asp98Phe’ and ‘Asp98 ® Phe’, to more exotic notations,
like ‘Asp98-Phe98’, ‘D98 to phenylalanine’ and ‘Asp 98
was mutated to phenylalanine’. Regular expressions are
used to identify residues and mutations.
Articles about GPCRs refer to mutations and residues
using one of four numbering schemes. The most frequently
Figure 1 Schematic flow-chart of the annotation process. On the left, processes coloured red are performed by Utopia Documents,
processes in blue by GPCRDB. On the right, is a screenshot of an annotated paper [29] in the Utopia Documents PDF reader, in which all
annotated concepts have been highlighted by pressing the space-bar (annotations appear as red highlights, both in the body of the text and in
the document margins).
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used are the standard sequential numbering scheme and
the scheme of Ballesteros-Weinstein [23]. Other articles
use the Oliveira scheme [24] (also known as the GPCRDB
numbering scheme), or their own, article-specific scheme.
The Ballesteros-Weinstein and Oliveira schemes are so-
called general residue numbering schemes. These allow
consistent residue numbering across multiple proteins,
independent of their sequential numbers. The underlying
principle is that residues with the same general residue
number have equivalent locations in their tertiary struc-
tures and consequently in the multiple sequence align-
ments. In the widely used Ballesteros-Weinstein scheme,
residue numbers are in the format ‘TM.n’, where the num-
ber before the period indicates the number of the trans-
membrane helix, and the number after the period indicates
the residue position with respect to the most conserved
residue position in the helix (e.g., ‘3.50’ denotes residue 50
in TM domain 3).
Some articles discuss residues and mutations using an
article-specific numbering scheme. Often, standard sequen-
tial residue numbers are used that do not exactly map to
the protein sequence in the database. This mismatch can
arise owing to inclusion of signal peptides in the sequence,
different isoforms, etc. In these cases, there is an offset by
which the residue numbers must be corrected to obtain a
valid mapping to the reference sequences in the database.
A regular expression-based approach is taken to calculate
the right offsets. When multiple offsets are possible (i.e.,
there are multiple ways of mapping the identified residues
on the sequence), the offset is chosen that is closest to the
residue numbers mentioned in the text.
Residues and mutations are grounded mainly based on
proximity to proteins mentioned in the text, favouring
combinations that occur within the same sentence. Valida-
tion of these combinations is performed by comparing the
identified residues and mutations to the sequences of the
candidate protein mentions, using similar approaches to
those discussed by Horn et al. [19]. Where general residue
numbers have been used, the sequential numbers are
retrieved from GPCRDB for all candidate protein
mentions.
Results
GPCRDB contains a substantial amount of information,
but for this to be useful, users require more than just large
collections of ‘data’. For the three concepts for which we
provide annotations (proteins, residues and mutations), we
have selected data, links and knowledge that we believe
will benefit users when reading an article, allowing them
to link effortlessly from the text to all relevant information
in GPCRDB. Once a paper is annotated, red marks on the
side of the pages indicate where annotated concepts are
located, as shown in Figure 1. The intensity of the red
marks increases with the number of annotations at those
positions. All annotated concepts can also be highlighted
simultaneously by pressing the space-bar.
Proteins
Protein annotations contain links to a number of
sources (Figure 2). A link pointing to the protein detail
page in GPCRDB is always present. Here, users can find
information relating to the protein sequence, mutations,
homology models, ligand-binding data, and so on. In
addition, a link to the protein family page is provided.
From here, all other protein family members can be
retrieved, multiple sequence alignments can be accessed,
etc.
Protein annotations also contain links to UniProtKB for
a detailed report on the protein, and, if available, a link to
Ensembl for the genomic view. We provide a list of syno-
nyms for the protein names. Structural information on
GPCRs is still limited, but we provide links to structures
when they are available. If oligomerisation information is
available, we provide links to pages that contain the rele-
vant details.
Residues
Residue annotations contain various links and a selection
of data pertinent to that specific residue (Figure 3).
The protein name is linked to its protein detail page in
GPCRDB. The residue type is displayed, together with its
residue number in several numbering schemes. General
residue numbers are provided in two different schemes:
the commonly used Ballesteros-Weinstein scheme, and
that of Oliveira et al. The sequential residue number is
also shown. Sequential residue numbers in GPCRDB
annotations may not be identical to residue numbers
described in an article. If the software has detected a mis-
match and made the appropriate corrections, this will be
noted in the annotation. A one-line description of the
location and interactions of the residue is given, based on
manual analysis of currently available protein structures. A
three-dimensional cartoon image of a GPCR structure is
provided, in which the position of the residue is high-
lighted. This allows readers to directly place the informa-
tion in the article in a structural context. If the residue is
located in a structurally conserved region of the Class A
GPCRs, and thus has a general residue number in
GPCRDB, a link is given that will create a YASARA scene
containing the homology model of the protein with the
residue highlighted in the structure. If the residue is part
of a reported oligomerisation interface, links to more
detailed descriptions of that interface are included. For
each residue, a link is provided to a GPCRDB page sum-
marising all known data and information for that residue,
including information about available mutations at that
position, and mutations at equivalent positions in other
proteins.
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Mutations
The mutation annotations also link to the protein detail
page. If GPCRDB contains information about the same
mutation from other literature, links to the relevant
PubMed pages are provided. This way, users can immedi-
ately look up literature that discusses the same mutation.
If GPCRDB contains mutations at the same position in
the same protein, but with a different mutated residue
type, links to relevant GPCRDB pages are provided.
A link to a page that displays mutations at the same
(equivalent) position in other proteins is always present. In
addition to links to other literature or other mutations,
GPCRDB contains a large amount of descriptive informa-
tion about the effects of mutations - such information has
been culled, over the years, from painstaking analysis of
the literature, and manually added to the knowledgebase
in the form of short summaries. Where such information
is present in the GPCRDB for the mutation at hand, this
information is provided automatically in the annotations
displayed in the side-bar. If the mutation is located at
a position in a structurally conserved region of the Class A
GPCRs, and thus has a general residue number in
GPCRDB, a link is given that will create a YASARA scene
containing the homology model of the protein, with the
wild-type and mutated residues highlighted in the struc-
ture. In addition to mutation-specific information, muta-
tion annotations also contain general information about
the mutated residue. This residue-specific annotation is
identical to the information displayed within residue anno-
tations (Figure 4).
Community annotations
With this work, we take the integration of literature data
in GPCRDB one step further. Using the PDF reader, when
a mutation is identified in a scientific article that is not yet
known to the GPCRDB, this mutation is automatically
integrated into the GPCRDB, making this information
available from both the GPCRDB website as well as from
Figure 2 Protein annotation of the human A2a adenosine receptor. On the left, part of a paper by Gao et al. [29] is shown; annotated
concepts are highlighted in red by pressing the space-bar. On the right, annotation for the A2a receptor (obtained by clicking on the words
indicated by the grey arrow) is shown. The protein identifier and family are linked to the protein detail and protein family pages in GPCRDB,
respectively. In addition, links to a number of external resources are provided. An image of the protein structure (PDB code 3EML) is shown.
Although not annotated in the text, the species mentioned (human, murine, bovine, rat) are used internally for protein normalisation.
Vroling et al. BMC Bioinformatics 2011, 12:362
http://www.biomedcentral.com/1471-2105/12/362
Page 5 of 10
the annotations within Utopia Documents. Thus, when a
user reads another article discussing a mutation at the
same position, links to the newly integrated article will
appear as an integral part of the annotation display, allow-
ing immediate navigation to the appropriate literature.
In addition, behind the scenes, for all articles anno-
tated using the reader, sentences are extracted in which
mutations are mentioned. This information, which effec-
tively provides an at-a-glance summary of the article
with respect to that mutation, is stored in the GPCRDB
and made available from the GPCRDB website. Because
we strive to include only the most highly relevant data
and information in the annotations offered by Utopia
Documents, this automatically extracted text is not dis-
played with the PDF reader, and is only accessible
through the GPCRDB website.
Annotations and the rescue of data
The integrated view of literature and data offered here is
invaluable when reading articles published before the
first X-ray structure of a GPCR, that of bovine rhodopsin
[25], became available. Prior to that moment, researchers
often interpreted their experimental results in the light of
homology models. The quality of those models was
usually very poor [26], and hence the interpretation of
the experimental data was often far from optimal, and
sometimes simply wrong. The experimental data are still
valuable though; today, with more information available,
scientists can re-interpret the data in light of current
knowledge. As an example, Figure 5 illustrates an image
from an old mutation study [27] in which the authors
describe various mutations in the guinea pig histamine
H1 receptor, building and validating a homology model
Figure 3 Annotation of residue Trp243 in the human adenosine A3 receptor. On the left, part of a paper by Gao et al. [29] is shown;
annotated concepts are highlighted in red by pressing the space-bar. On the right are the residue annotations. The protein name is linked to
the protein detail page in GPCRDB. Links are also provided to a page in GPCRDB listing all available information for this residue, and to a
YASARA [30] scene, in which the residue is highlighted. Residue numbers are provided both in the sequential numbering scheme and in the
Ballesteros-Weinstein and Oliveira (GPCRDB) schemes. A short description of the location and interactions of this residue is provided, as well as a
cartoon indicating its location in the receptor structure.
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using these data, and arguing, for example, that residue
Trp161 plays an important role in receptor-ligand bind-
ing. This assumption was based on the effect of the
mutation on receptor function, leading to a model in
which Trp161 was (wrongly) modelled as being posi-
tioned in the ligand-binding site.
By contrast, the annotation indicates that this residue,
located in TM IV, points towards the membrane and
possibly interacts with cholesterol (Figure 5). This is a
completely different view from that proposed by the
authors. Looking at the model provided by GPCRDB,
based on sub-family specific profiles and the latest
Figure 4 Annotation of mutation R283A in the mouse thyrotropin-releasing hormone receptor. On the left, part of a paper by Gao et al.
[29] is shown; annotated concepts are highlighted in red by pressing the space-bar. On the right are the mutation annotations. Papers
discussing the same mutation are listed, with links to PubMed. A short literature-based summary of the effects of this mutation is provided,
together with links to GPCRDB pages giving details of other mutations at the same position, and to a YASARA [30] scene, in which the mutated
residue is highlighted and displayed with the mutant residue type. Information about the wild-type residue is also provided, which is identical to
the information displayed for residue annotations.
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crystal structures, it can be seen that the position
of Trp161 with respect to the ligand-binding pocket
is completely obscured by TM III and hence that a
direct role in receptor-ligand binding is highly unlikely
(Figure 6).
The point here is not that the Wieland model is incor-
rect; as stated before, most models were wrong before
the structure of bovine rhodopsin was published. What is
important is that this software can be used to detect
these types of historical artifacts, relieving scientists of
the task of validating the results of ‘old’ literature against
current knowledge. It is important to emphasise that the
published experimental data are still valuable, but need
new interpretation: in a sense, the software rescues old
data from articles that contain interpretations that we
now know to be incorrect. With this tool, therefore,
scientists can now focus on providing new views on
experimental data in the light of current knowledge. For
example, knowing that Trp161 is conserved and interacts
with cholesterol in some receptor structures allows for
the hypotheses that this residue is functionally important
for dimer formation, potentially through cholesterol.
Other hypotheses can be imagined too, but the only
thing that seems certain is that Trp161 is not directly
involved in ligand binding.
Applications
The system presented here is likely to be useful in a
number of different scenarios. For example, for biocura-
tors, it offers a rapid means of accessing reliable, contex-
tualised GPCR-relevant data: this would not only benefit
future curators of GPCR-specific resources like
GPCRDB, but would also facilitate the work of those
who annotate more general repositories, such as Uni-
ProtKB:Swiss-Prot or InterPro [28]. For journal editors,
it offers a swift route to ‘gold standard’ GPCR data that
they may officially endorse as part of their manuscript
mark-up process. For life scientists and bioinformati-
cians in general, and for pharmacologists and target-dis-
covery researchers in particular, it offers a convenient
way to keep up with GPCR literature, and to find new
articles and new links that they might otherwise have
Figure 5 Excerpt from the article by Wieland et al.[27]. Trp161 is discussed as having interactions with the cis-aromatic ring of the ligand.
The annotation of residue Trp161 is shown on the right as it appears in Utopia.
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overlooked. For users of GPCRDB, it offers a swifter,
more targeted and hence more convenient navigation
system compared to simple Web-based browsing of the
resource. Many other use cases are likely as the system
is generalised to other superfamilies.
Conclusions
The work presented here was developed in response to
the need to achieve tighter coupling between published
articles and their underlying data as a crucial step
towards knowledge discovery. The strength of our
approach lies in its ability to present users (life science
researchers, bioinformaticians, researchers in the phar-
maceutical industry, journal editors, and so on) with
current, integrated, validated, internally consistent data
and information in the context of literature being read.
The annotations provided are extensive and detailed,
and, importantly, include concepts such as ‘residue A
interacts with the ligand’, ‘residue B is implicated as
playing a role in oligomeric interactions’, ‘residue C is
located in TM4 and points to the lipid environment’,
‘residue D is conserved in its sub-family’, etc. A substan-
tial amount of knowledge is sequestered in such annota-
tions. Taking mutation annotations as an example,
although trivial at first glance, the mapping of sequential
residue numbers to those of general residue numbering
schemes saves researchers large amounts of time in
looking up the residue mentioned in the database and
finding its associated general residue number. In order
to reliably transfer information between different pro-
teins, this is a necessary but very time-consuming pro-
cess. The structural information consists of data from a
variety of different manually- or automatically-generated
sources, and provides scientists with a structural per-
spective on the concepts in the text, making it much
easier to critically assess the authors’ interpretations of
experimental results, which is crucially important when
reading old literature. Linking mutation data to other
articles in which similar mutations have been discussed
saves users considerable effort. This is an onerous task
to perform by hand, owing to the necessary conversions
between various numbering schemes and residue num-
bering offsets. To summarise, this work helps GPCR
researchers to optimally extract new knowledge from
scientific literature by automatically putting data from a
PDF article in the wider context of the total body of
knowledge related to GPCRs.
Availability and requirements
Project name: GPCR-specific PDF reader
Project home page: http://www.gpcr.org/7tm
Operating systems: Mac OS (10.5 or newer), Windows
(XP or newer), Ubuntu linux (10.4 or newer), Debian
linux (6.0 or newer)
Programming language: C++, Java, Python
Other requirements: None
Figure 6 The location of Trp161. On the left, the model from the paper by Wieland et al. [27] to which orange and red ellipses have been
added to highlight helices III and IV respectively. On the right, the model retrieved from GPCRDB, with helices III and IV drawn in orange and
red. The grey sphere shows the approximate position of the ligand-binding pocket.
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License: http://www.getutopia.com/documents/License.
txt
Any restrictions to use by non-academics: None
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MCSIS: Molecular Class-Specific Information System; GPCR: G Protein-Coupled
Receptor; PDF: Portable Document Format; SOAP: Simple Object Access
Protocol
Acknowledgements
This work was performed within the framework of Dutch Top Institute
Pharma, project “The GPCR forum” (project nr. D1-105). This work was
supported by the BioRange program of the Netherlands Bioinformatics
Centre (NBIC), which is supported by a BSIK grant through the Netherlands
Genomics Initiative (NGI). We thank Rob Leurs for stimulating discussions.
Author details
1CMBI, NCMLS, Radboud University Nijmegen Medical Centre, Geert
Grooteplein 26-28, Nijmegen, 6525 GA, The Netherlands. 2School of
Computer Science, University of Manchester, Kilburn Building, Oxford Road,
Manchester, M13 9PL, UK. 3Faculty of Life Sciences, University of Manchester,
Michael Smith Building, Oxford Road, Manchester, M13 9PT, UK.
Authors’ contributions
BV drafted the manuscript and wrote the GPCRDB-specific software. BV, DT,
PM and SP participated in the writing of the Utopia Documents plugin. DT,
PM and SP wrote the Utopia Documents software and adapted it to be
used with the GPCRDB plugin. GV supervised the project. GV & TA helped
write the manuscript and draft Figure 6. All authors have read and approved
the final manuscript.
Received: 28 June 2011 Accepted: 12 September 2011
Published: 12 September 2011
References
1. Cochrane GR, Galperin MY: The 2010 Nucleic Acids Research Database
Issue and online Database Collection: a community of data resources.
Nucleic Acids Res 2010, 38:D1-4.
2. Roos DS: Computational biology. Bioinformatics–trying to swim in a sea
of data. Science 2001, 291:1260-1261.
3. Vroling B, Sanders M, Baakman C, Borrmann A, Verhoeven S, Klomp J,
Oliveira L, de Vlieg J, Vriend G: GPCRDB: information system for G
protein-coupled receptors. Nucleic Acids Res 2011, 39:D309-319.
4. Horn F, Weare J, Beukers MW, Hörsch S, Bairoch A, Chen W, Edvardsen O,
Campagne F, Vriend G: GPCRDB: an information system for G protein-
coupled receptors. Nucleic Acids Res 1998, 26:275-279.
5. Seringhaus MR, Gerstein MB: Publishing perishing? Towards tomorrow’s
information architecture. BMC Bioinformatics 8:17-17.
6. Santos C, Blake J, States DJ: Supplementary data need to be kept in
public repositories. Nature 2005, 438:738.
7. Editorial ALPSP/Charlesworth Awards 2007. Learn Pub 2007, 20:317-318.
8. Chatr-aryamontri A, Ceol A, Palazzi LM, Nardelli G, Schneider MV,
Castagnoli L, Cesareni G: MINT: the Molecular INTeraction database.
Nucleic Acids Res 2007, 35:D572-574.
9. Shotton D, Portwin K, Klyne G, Miles A: Adventures in semantic
publishing: exemplar semantic enhancements of a research article. PLoS
Comput Biol 2009, 5:e1000361.
10. Fink JL, Kushch S, Williams PR, Bourne PE: BioLit: integrating biological
literature with databases. Nucleic Acids Res 2008, 36:W385-389.
11. Pafilis E, O’Donoghue SI, Jensen LJ, Horn H, Kuhn M, Brown NP,
Schneider R: Reflect: augmented browsing for the life scientist. Nat
Biotechnol 2009, 27:508-510.
12. Attwood TK, Kell DB, McDermott P, Marsh J, Pettifer SR, Thorne D: Calling
International Rescue: knowledge lost in literature and data landslide!
Biochem J 2009, 424:317-333.
13. Attwood TK, Kell DB, McDermott P, Marsh J, Pettifer SR, Thorne D: Utopia
documents: linking scholarly literature with research data. Bioinformatics
2010, 26:i568-i574.
14. Morgan AA, Lu Z, Wang X, Cohen AM, Fluck J, Ruch P, Divoli A, Fundel K,
Leaman R, Hakenberg J, Sun C, Liu H-hui, Torres R, Krauthammer M,
Lau WW, Liu H, Hsu C-N, Schuemie M, Cohen KB, Hirschman L: Overview of
BioCreative II gene normalization. Genome Biol 2008, 9:S3-S3.
15. Krallinger M, Valencia A, Hirschman L: Linking genes to literature: text
mining, information extraction, and retrieval applications for biology.
Genome Biol 2008, 9:S8-S8.
16. Lee LC, Horn F, Cohen FE: Automatic extraction of protein point
mutations using a graph bigram association. PLoS Comput Biol 2007, 3:
e16.
17. Laurila JB, Naderi N, Witte R, Riazanov A, Kouznetsov A, Baker CJO:
Algorithms and semantic infrastructure for mutation impact extraction
and grounding. BMC Genomics 2010, 11(Suppl 4):S24.
18. Winnenburg R, Plake C, Schroeder M: Improved mutation tagging with
gene identifiers applied to membrane protein stability prediction. BMC
Bioinformatics 2009, 10:S3.
19. Horn F, Lau AL, Cohen FE: Automated extraction of mutation data from
the literature: application of MuteXt to G protein-coupled receptors and
nuclear hormone receptors. Bioinformatics 2004, 20:557-568.
20. The Universal Protein Resource (UniProt) in 2010. Nucleic Acids Res 2010,
38:D142-148.
21. Gerner M, Nenadic G, Bergman CM: LINNAEUS: a species name
identification system for biomedical literature. BMC Bioinformatics 2010,
11:85.
22. Wheeler DL, Barrett T, Benson DA, Bryant SH, Canese K, Chetvernin V,
Church DM, Dicuccio M, Edgar R, Federhen S, Feolo M, Geer LY,
Helmberg W, Kapustin Y, Khovayko O, Landsman D, Lipman DJ, Madden TL,
Maglott DR, Miller V, Ostell J, Pruitt KD, Schuler GD, Shumway M,
Sequeira E, Sherry ST, Sirotkin K, Souvorov A, Starchenko G, Tatusov RL,
et al: Database resources of the National Center for Biotechnology
Information. Nucleic Acids Res 2008, 36:D13-21.
23. Ballesteros JA, Weinstein H: Integrated methods for the construction of
three-dimensional models and computational probing of structure-
function relations in G protein-coupled receptors. METHODS IN
NEUROSCIENCES-LONDON 1995, 25:366-366.
24. Oliveira L, Paiva A, Vriend G: A common motif in G-protein-coupled seven
transmembrane helix receptors. J Comp Aided Mol Des 1993, 649-658.
25. Palczewski K, Kumasaka T, Hori T, Behnke CA, Motoshima H, Fox BA, Le
Trong I, Teller DC, Okada T, Stenkamp RE, Yamamoto M, Miyano M: Crystal
structure of rhodopsin: A G protein-coupled receptor. Science 2000,
289:739-745.
26. Oliveira L, Hulsen T, Lutje Hulsik D, Paiva ACM, Vriend G: Heavier-than-air
flying machines are impossible. FEBS Lett 2004, 564:269-273.
27. Wieland K, Laak AM, Smit MJ, Kühne R, Timmerman H, Leurs R: Mutational
analysis of the antagonist-binding site of the histamine H(1) receptor.
J Biol Chem 1999, 274:29994-30000.
28. Hunter S, Apweiler R, Attwood TK, Bairoch A, Bateman A, Binns D, Bork P,
Das U, Daugherty L, Duquenne L, Finn RD, Gough J, Haft D, Hulo N,
Kahn D, Kelly E, Laugraud A, Letunic I, Lonsdale D, Lopez R, Madera M,
Maslen J, McAnulla C, McDowall J, Mistry J, Mitchell A, Mulder N, Natale D,
Orengo C, Quinn AF, et al: InterPro: the integrative protein signature
database. Nucleic Acids Res 2009, 37:D211-215.
29. Gao Z-G, Chen A, Barak D, Kim S-K, Müller CE, Jacobson KA: Identification
by site-directed mutagenesis of residues involved in ligand recognition
and activation of the human A3 adenosine receptor. J Biol Chem 2002,
277:19056-19063.
30. Krieger E, Joo K, Lee J, Lee J, Raman S, Thompson J, Tyka M, Baker D,
Karplus K: Improving physical realism, stereochemistry, and side-chain
accuracy in homology modeling: Four approaches that performed well
in CASP8. Proteins 2009, 77(Suppl 9):114-122.
doi:10.1186/1471-2105-12-362
Cite this article as: Vroling et al.: Integrating GPCR-specific information
with full text articles. BMC Bioinformatics 2011 12:362.
Vroling et al. BMC Bioinformatics 2011, 12:362
http://www.biomedcentral.com/1471-2105/12/362
Page 10 of 10
